ERBB2 and breast carcinoma: They found that the conjugate 249 (Ab-PROTAC 3) only induced the degradation of BRD4 protein in HER2-positive breast cancer cell lines (SK-BR-3 and BT474), but not in HER2-negative cells (MCF-7 and MDA-MB 231).